• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮血栓性动静脉瘘的治疗:临床和经济意义。

Percutaneous treatment of thrombosed arteriovenous fistulas: clinical and economic implications.

机构信息

Nephrology Research and Development Unit, Hospital S. João, Porto, Portugal.

出版信息

Clin J Am Soc Nephrol. 2010 Dec;5(12):2245-50. doi: 10.2215/CJN.03070410. Epub 2010 Aug 26.

DOI:10.2215/CJN.03070410
PMID:20798249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2994086/
Abstract

BACKGROUND AND OBJECTIVES

Maintenance of previously thrombosed arteriovenous fistulas (AVFs) as functional vascular accesses can be highly expensive, with relevant financial implications for healthcare systems. The aim of our study was to evaluate the costs and health outcomes of vascular access care in hemodialysis patients with AVF thrombosis.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective, controlled cohort study was performed among local hemodialysis patients with completely thrombosed AVFs between August 1, 2007, and July 1, 2008. Detailed clinical and demographic information was collected and a comprehensive measure of total vascular access costs was obtained. Costs are reported in 2009 U.S. dollars.

RESULTS

A total of 63 consecutive hemodialysis patients with thrombosed AVFs were identified--a cohort of 37 patients treated with percutaneous thrombectomy and a historic cohort of 25 patients with abandoned thrombosed AVFs. The mean cost of all vascular access care at 6 months was $2479. Salvage of thrombosed AVFs led to a near two-fold reduction in access-related expenses, per patient-month at risk ($375 versus $706; P = 0.048). The costs for access-related hospitalizations ($393 versus $91; P = 0.050), management of access dysfunction ($106 versus $28; P = 0.005), and surgical interventions ($35 versus $6; P = 0.001) were also significantly lower in the percutaneous treatment group. At 6 months, most of these patients had a functional AVF as permanent vascular access (91% versus 33%, P = 0.0001).

CONCLUSIONS

Salvage of thrombosed AVF is a highly efficient procedure; therefore, intensive efforts should be undertaken to universalize these interventions.

摘要

背景与目的

维持先前血栓形成的动静脉瘘(AVF)作为功能性血管通路可能非常昂贵,这对医疗保健系统有重大的财务影响。我们研究的目的是评估血栓形成的 AVF 血液透析患者血管通路护理的成本和健康结果。

设计、设置、参与者和测量:这是一项在 2007 年 8 月 1 日至 2008 年 7 月 1 日期间完全血栓形成的 AVF 的本地血液透析患者中进行的回顾性、对照队列研究。收集了详细的临床和人口统计学信息,并获得了全面的总血管通路成本测量。成本以 2009 年美元报告。

结果

确定了总共 63 例连续血栓形成的 AVF 血液透析患者-一组 37 例接受经皮血栓切除术治疗的患者和一组 25 例放弃血栓形成的 AVF 的历史队列。6 个月时所有血管通路护理的平均成本为 2479 美元。血栓形成的 AVF 挽救导致与通路相关的费用降低近一倍,每患者风险月费用(375 美元对 706 美元;P = 0.048)。经皮治疗组的与通路相关的住院费用(393 美元对 91 美元;P = 0.050)、通路功能障碍的管理费用(106 美元对 28 美元;P = 0.005)和手术干预费用(35 美元对 6 美元;P = 0.001)也明显降低。在 6 个月时,这些患者中的大多数都有功能正常的 AVF 作为永久性血管通路(91%对 33%,P = 0.0001)。

结论

血栓形成的 AVF 挽救是一种非常有效的方法;因此,应努力普及这些干预措施。

相似文献

1
Percutaneous treatment of thrombosed arteriovenous fistulas: clinical and economic implications.经皮血栓性动静脉瘘的治疗:临床和经济意义。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2245-50. doi: 10.2215/CJN.03070410. Epub 2010 Aug 26.
2
Percutaneous salvage of thrombosed immature arteriovenous fistulas.经皮挽救血栓形成的未成熟动静脉内瘘
Semin Dial. 2011 Jan-Feb;24(1):107-14. doi: 10.1111/j.1525-139X.2011.00846.x.
3
Percutaneous angioplasty in the treatment of thrombosed hemodialysis fistulas: A single-center experience with 1 year of follow-up.经皮腔内血管成形术治疗血栓形成的血液透析瘘:单中心 1 年随访经验。
Turk Kardiyol Dern Ars. 2020 Nov;48(8):754-759. doi: 10.5543/tkda.2020.33027.
4
A novel technique for duplex-guided office-based interventions for patients with acute arteriovenous fistula occlusion.一种用于急性动静脉瘘闭塞患者的基于诊室的双引导介入治疗的新方法。
J Vasc Surg. 2018 Mar;67(3):857-859. doi: 10.1016/j.jvs.2017.07.135. Epub 2017 Oct 7.
5
Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.美国血液透析患者动静脉瘘相关的医疗保险费用。
Am J Kidney Dis. 2018 Jul;72(1):10-18. doi: 10.1053/j.ajkd.2018.01.034. Epub 2018 Mar 28.
6
Cost-effectiveness of repeated interventions on failing arteriovenous fistulas.重复干预失败动静脉瘘的成本效益。
J Vasc Surg. 2019 Nov;70(5):1620-1628. doi: 10.1016/j.jvs.2019.01.085. Epub 2019 May 27.
7
Economic repercussions of implementing a protocol for urgent surgical repair of thrombosed arteriovenous fistulae.实施血栓形成动静脉瘘紧急手术修复方案的经济影响
Nefrologia. 2014 May 21;34(3):377-82. doi: 10.3265/Nefrologia.pre2014.Feb.12347. Epub 2014 Mar 25.
8
Hemodialysis Vascular Access: Rising Costs as a Surrogate Marker for Patency and Function of Arteriovenous Fistulas.血液透析血管通路:费用上升作为动静脉内瘘通畅性和功能的替代指标
Ann Vasc Surg. 2017 Jan;38:136-143. doi: 10.1016/j.avsg.2016.08.003. Epub 2016 Aug 19.
9
Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas.Ellipsys经皮与前臂近端Gracz型手术动静脉内瘘的比较
Am J Kidney Dis. 2021 Oct;78(4):520-529.e1. doi: 10.1053/j.ajkd.2021.01.011. Epub 2021 Mar 1.
10
Choice of a second vascular access in hemodialysis patients whose initial arteriovenous fistula failed to mature.初始动静脉内瘘未成熟的血液透析患者的第二种血管通路选择。
J Vasc Surg. 2018 Dec;68(6):1858-1864.e1. doi: 10.1016/j.jvs.2018.03.419. Epub 2018 Jun 21.

引用本文的文献

1
IN.PACT AV Access Randomized Trial of Drug-Coated Balloons for Dysfunctional Arteriovenous Fistulae: Clinical Outcomes through 36 Months.IN.PACT AV _access_ 随机试验:药物涂层球囊治疗功能不良动静脉瘘:36 个月的临床结果。
J Vasc Interv Radiol. 2023 Dec;34(12):2093-2102.e7. doi: 10.1016/j.jvir.2023.07.007. Epub 2023 Jul 17.
2
Hemodialysis Vascular access maintenance in the Covid-19 pandemic: Positioning paper from the Interventional Nephrology Committee of the Brazilian Society of Nephrology.新冠疫情期间血液透析血管通路维护:巴西肾脏病学会介入肾脏病学委员会的立场文件
J Bras Nefrol. 2020 Aug 26;42(2 suppl 1):41-43. doi: 10.1590/2175-8239-JBN-2020-S110.
3
Salvage of thrombosed arteriovenous fistulae of patients on hemodialysis: report on the experience of a Brazilian center.血液透析患者血栓形成的动静脉内瘘挽救:巴西一家中心的经验报告。
J Bras Nefrol. 2018 Oct-Dec;40(4):351-359. doi: 10.1590/2175-8239-jbn-2018-0036. Epub 2018 Aug 30.
4
Maintaining Patency of Vascular Access for Haemodialysis.维持血液透析血管通路的通畅性。
Cardiovasc Eng Technol. 2017 Sep;8(3):240-243. doi: 10.1007/s13239-017-0320-3. Epub 2017 Jul 18.
5
Dialysis: Early pre-emptive intervention might reduce AVF access loss.透析:早期先发制人的干预可能会减少动静脉内瘘的通路丧失。
Nat Rev Nephrol. 2014 Jan;10(1):9-10. doi: 10.1038/nrneph.2013.255. Epub 2013 Dec 3.
6
Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients.透析患者首发时血液透析和腹膜透析通路的成本分析。
Perit Dial Int. 2013 Nov-Dec;33(6):662-70. doi: 10.3747/pdi.2011.00309. Epub 2013 Mar 1.

本文引用的文献

1
Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis-access thrombosis.血管造影和预防性血管成形术预防血液透析通路血栓形成的经济学分析。
Catheter Cardiovasc Interv. 2010 Jan 1;75(1):14-21. doi: 10.1002/ccd.22247.
2
Surgical or endovascular repair of thrombosed dialysis vascular access: is there any evidence?血栓形成的透析血管通路的外科手术或血管内修复:有证据吗?
J Vasc Surg. 2009 Oct;50(4):953-6. doi: 10.1016/j.jvs.2009.06.058.
3
Fistula salvage by endovascular therapy.通过血管内治疗挽救瘘管。
Adv Chronic Kidney Dis. 2009 Sep;16(5):339-51. doi: 10.1053/j.ackd.2009.06.001.
4
Outcomes of percutaneous mechanical thrombectomy of arteriovenous fistulas in hemodialysis patients.血液透析患者动静脉内瘘经皮机械血栓切除术的疗效
Semin Dial. 2008 Nov-Dec;21(6):581-3. doi: 10.1111/j.1525-139X.2008.00504.x. Epub 2008 Oct 6.
5
Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study.在临床监测中增加通路血流量监测可降低血栓形成率和成本,并在短期内提高内瘘通畅率:一项对照队列研究。
Nephrol Dial Transplant. 2008 Nov;23(11):3578-84. doi: 10.1093/ndt/gfn275. Epub 2008 May 29.
6
Non-surgical salvage of thrombosed arterio-venous fistulae: a case series and review of the literature.血栓形成的动静脉内瘘的非手术挽救:病例系列及文献综述
Semin Dial. 2007 Sep-Oct;20(5):459-64. doi: 10.1111/j.1525-139X.2007.00356.x.
7
Fistula first initiative: advantages and pitfalls.瘘管优先策略:优势与陷阱
Clin J Am Soc Nephrol. 2007 Sep;2(5):1043-53. doi: 10.2215/CJN.01080307. Epub 2007 Aug 16.
8
Effect of change in vascular access on patient mortality in hemodialysis patients.血管通路改变对血液透析患者死亡率的影响。
Am J Kidney Dis. 2006 Mar;47(3):469-77. doi: 10.1053/j.ajkd.2005.11.023.
9
Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas.单中心使用Arrow-Trerotola经皮血栓切除术装置治疗自体动静脉内瘘血栓形成的经验。
J Vasc Interv Radiol. 2005 Dec;16(12):1605-11. doi: 10.1097/01.RVI.0000182157.48697.F5.
10
Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes.血液透析患者的带隧道导管:原因及后续结果。
Am J Kidney Dis. 2005 Sep;46(3):501-8. doi: 10.1053/j.ajkd.2005.05.024.